Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Crit Care. 2020 Aug 20;24(1):513. doi: 10.1186/s13054-020-03217-6.
The optimal MAP target for patients with cardiogenic shock (CS) remains unknown. We sought to determine the relationship between mean arterial pressure (MAP) and mortality in the cardiac intensive care unit (CICU) patients with CS.
Using a single-center database of CICU patients admitted between 2007 and 2015, we identified patients with an admission diagnosis of CS. MAP was measured every 15 min, and the mean of all MAP values during the first 24 h (mMAP) was recorded. Multivariable logistic regression determined the relationship between mMAP and adjusted hospital mortality.
We included 1002 patients with a mean age of 68 ± 13.7 years, including 36% females. Admission diagnoses included acute coronary syndrome in 60%, heart failure in 74%, and cardiac arrest in 38%. Vasoactive drugs were used in 72%. The mMAP was higher (75 vs. 71 mmHg, p < 0.001) among hospital survivors (66%) compared with non-survivors (34%). Hospital mortality was inversely associated with mMAP (adjusted OR 0.9 per 5 mmHg higher mMAP, p = 0.01), with a stepwise increase in hospital mortality at lower mMAP. Patients with mMAP < 65 mmHg were at higher risk of hospital mortality (57% vs. 28%, adjusted OR 2.0, 95% CI 1.4-3.0, p < 0.001); no differences were observed between patients with mMAP 65-74 vs. ≥ 75 mmHg (p > 0.1).
In patients with CS, we observed an inverse relationship between mMAP and hospital mortality. The poor outcomes in patients with mMAP < 65 mmHg provide indirect evidence supporting a MAP goal of 65 mmHg for patients with CS.
心源休克(CS)患者的最佳平均动脉压(MAP)目标仍不清楚。我们旨在确定 CS 患者入住心脏重症监护病房(CICU)期间 MAP 与死亡率之间的关系。
我们使用 2007 年至 2015 年期间收治的 CICU 患者的单中心数据库,确定了入院诊断为 CS 的患者。每 15 分钟测量一次 MAP,记录前 24 小时内所有 MAP 值的平均值(mMAP)。多变量逻辑回归确定了 mMAP 与调整后的住院死亡率之间的关系。
我们纳入了 1002 名平均年龄为 68±13.7 岁的患者,其中 36%为女性。入院诊断包括急性冠状动脉综合征 60%,心力衰竭 74%,心脏骤停 38%。72%的患者使用了血管活性药物。与非幸存者(34%)相比,幸存者(66%)的 mMAP 更高(75 与 71mmHg,p<0.001)。住院死亡率与 mMAP 呈负相关(每升高 5mmHg 调整后的 OR 为 0.9,p=0.01),mMAP 越低,住院死亡率呈阶梯式上升。mMAP<65mmHg 的患者住院死亡率更高(57%与 28%,调整后的 OR 为 2.0,95%CI 1.4-3.0,p<0.001);mMAP 为 65-74mmHg 与≥75mmHg 之间的患者差异无统计学意义(p>0.1)。
在 CS 患者中,我们观察到 mMAP 与住院死亡率之间呈反比关系。mMAP<65mmHg 的患者预后不良,为 CS 患者设定 65mmHg 的 MAP 目标提供了间接证据。